Zdrowie i gospodarka · 09/12/2020
FDA Releases Final Guidance on Proprietary Names for Human Prescription Drugs
The FDA has released a final guidance document outlining best practices for developing and selecting proprietary names for human prescription drugs to minimize medication errors and ensure compliance with federal regulations.
Source: Federal Register — Food and Drug AdministrationOpen original release →